Search research articles
Contact Us
Filters
Showing results (21-30 of 109) with videos related to
Page
of 11
Sort By:
Neurochemical Research
|
August 2, 2001
Th1 cytokines stimulate RANTES chemokine secretion by human astroglial cells depending on de novo transcription
Q Q Li, C T Bever
Springer Seminars in Immunopathology
|
January 1, 1985
Proteinases in inflammatory demyelinating disease
C T Bever, J N Whitaker
Neurology
|
October 26, 1999
Matrix metalloproteinases in multiple sclerosis: targets of therapy or markers of injury?
C T Bever, G A Rosenberg
International Journal of Molecular Medicine
|
June 16, 2001
Comparison of RANTES chemokine induction by Th1 cytokines in human astroglial cell lines
Q Q Li, C T Bever
Journal of Neuroimmunology
|
July 1, 1993
Clinical trials of interferons in multiple sclerosis. What have we learned?
H S Panitch, C T Bever
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 9, 2016
Tribute to John F. Kurtzke, MD, FACP, FAAN: 1926-2015
Christopher T Bever, Mitchell T Wallin
Perception
|
January 1, 1984
Extending the perception of shape from known to unknown shading
K Berbaum, T Bever, C S Chung
Pharmacology & Therapeutics
|
February 14, 2006
Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment
Susan I V Judge, Christopher T Bever
Perception
|
January 1, 1983
Light source position in the perception of object shape
K Berbaum, T Bever, C S Chung
Immunopharmacology and Immunotoxicology
|
May 1, 1997
Endotoxin induces increased intracellular cathepsin B activity in THP-1 cells
Q Li, W A Falkler, C T Bever
Page
of 11
Search research articles
Search
Showing results (21-30 of 109) with videos related to
Sort By:
Page
of 11
Neurochemical Research
|
August 2, 2001
Th1 cytokines stimulate RANTES chemokine secretion by human astroglial cells depending on de novo transcription
Q Q Li, C T Bever
Springer Seminars in Immunopathology
|
January 1, 1985
Proteinases in inflammatory demyelinating disease
C T Bever, J N Whitaker
Neurology
|
October 26, 1999
Matrix metalloproteinases in multiple sclerosis: targets of therapy or markers of injury?
C T Bever, G A Rosenberg
International Journal of Molecular Medicine
|
June 16, 2001
Comparison of RANTES chemokine induction by Th1 cytokines in human astroglial cell lines
Q Q Li, C T Bever
Journal of Neuroimmunology
|
July 1, 1993
Clinical trials of interferons in multiple sclerosis. What have we learned?
H S Panitch, C T Bever
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 9, 2016
Tribute to John F. Kurtzke, MD, FACP, FAAN: 1926-2015
Christopher T Bever, Mitchell T Wallin
Perception
|
January 1, 1984
Extending the perception of shape from known to unknown shading
K Berbaum, T Bever, C S Chung
Pharmacology & Therapeutics
|
February 14, 2006
Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment
Susan I V Judge, Christopher T Bever
Perception
|
January 1, 1983
Light source position in the perception of object shape
K Berbaum, T Bever, C S Chung
Immunopharmacology and Immunotoxicology
|
May 1, 1997
Endotoxin induces increased intracellular cathepsin B activity in THP-1 cells
Q Li, W A Falkler, C T Bever
Page
of 11